Follow
Mark Peterson
Mark Peterson
Chief Operating Officer, Cyclenium Pharma Inc.
Verified email at cyclenium.com - Homepage
Title
Cited by
Cited by
Year
Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery
E Marsault, ML Peterson
Journal of medicinal chemistry 54 (7), 1961-2004, 2011
9012011
Synthesis and biological evaluation of 4-purinylpyrrolidine nucleosides
ML Peterson, R Vince
Journal of medicinal chemistry 34 (9), 2787-2797, 1991
1171991
Methods of using macrocyclic modulators of the ghrelin receptor
GL Fraser, HR Hoveyda, ML Peterson
US Patent 7,491,695, 2009
892009
Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): Development of ulimorelin (TZP-101) from hit to clinic
HR Hoveyda, E Marsault, R Gagnon, AP Mathieu, M Vézina, A Landry, ...
Journal of medicinal chemistry 54 (24), 8305-8320, 2011
822011
Discovery of a new class of macrocyclic antagonists to the human motilin receptor
E Marsault, HR Hoveyda, ML Peterson, C Saint-Louis, A Landry, ...
Journal of medicinal chemistry 49 (24), 7190-7197, 2006
772006
Macrocyclic modulators of the ghrelin receptor
HR Hoveyda, ML Peterson, GL Fraser, M Ramaseshan
US Patent 7,476,653, 2009
612009
Practical Medicinal Chemistry with Macrocycles: Design, Synthesis, and Case Studies
E Marsault, ML Peterson
John Wiley & Sons, 2017
532017
Efficient parallel synthesis of macrocyclic peptidomimetics
E Marsault, HR Hoveyda, R Gagnon, ML Peterson, M Vézina, ...
Bioorganic & medicinal chemistry letters 18 (16), 4731-4735, 2008
482008
Macrocyclic antagonists of the motilin receptor
GL Fraser, É Marsault, M Peterson, H Hoveyda, S Beaubien, K Benakli, ...
US Patent 7,521,420, 2009
412009
Synthesis and biological evaluation of carbocyclic analogs of lyxofuranosides of 2-amino-6-substituted purines and 2-amino-6-substituted-8-azapurines
ML Peterson, R Vince
Journal of medicinal chemistry 33 (4), 1214-1219, 1990
401990
Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
HR Hoveyda, E Marsault, H Thomas, G Fraser, S Beaubien, A Mathieu, ...
US Patent App. 12/916,205, 2011
322011
Macrocyclic ghrelin receptor modulators and methods of using the same
H Hoveyda, GL Fraser, K Benakli, S Beauchemin, M Brassard, E Marsault, ...
US Patent 9,371,297, 2016
302016
Methods of using macrocyclic modulators of the ghrelin receptor
GL Fraser, HR Hoveyda, ML Peterson
US Patent 8,450,268, 2013
282013
Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders
GL Fraser, HR Hoveyda, ML Peterson
US Patent 8,088,733, 2012
262012
Spatially-defined macrocycles incorporating peptide bond surrogates
P Deslongchamps, Y Dory, L Ouellet, G Villeneuve, M Ramaseshan, ...
US Patent 7,550,431, 2009
252009
Intermediates for macrocyclic compounds
E Marsault, K Benakli, H Hoveyda, ML Peterson, S Beaubien, L Ouellet, ...
US Patent 10,040,751, 2018
23*2018
Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonists
P Deslongchamps, Y Dory, M Peterson, K Benakli, E Marsault, L Ouellet, ...
US Patent 7,452,862, 2008
182008
Methods of using macrocyclic modulators of the ghrelin receptor
GL Fraser, HR Hoveyda, ML Peterson
US Patent App. 12/635,871, 2011
162011
Macrocyclic modulators of the ghrelin receptor
H Hoveyda, ML Peterson, GL Fraser, M Ramaseshan
US Patent App. 12/636,048, 2010
162010
Macrocyclic Modulators of the Ghrelin Receptor
E Marsault, L Ouellet, C St-Louis, S Beaubien, K Benakli, HR Hoveyda, ...
US Patent App. 12/263,179, 2009
162009
The system can't perform the operation now. Try again later.
Articles 1–20